Keeping you up to date on recent developments in oncology, including: CD161 identified as impediment to immune response in diffuse glioma; iPSCs give sneak preview of AML; A role for chloroquine in cancer; Fecal transplant may aid in response to immunotherapy in melanoma.
A study led by scientists at the Korean Research Institute of BioScience and Biotechnology in Daejeon is the first to demonstrate that Dilp8/INSL3-Lgr3/8-NUCB, neuropeptide y signaling may be a potential therapeutic target in cancer anorexia and cachexia, which is associated with increased cancer mortality.
As of the end of January, SARS-CoV-2 has demonstrably infected more than 100 million individuals globally. It has killed more than 2 million. And the long-term sequelae of COVID infections – to say nothing of the health consequences of grief, social isolation and widespread economic distress – are still unfolding and will be for years to come.
Twenty years to the month after the completion of the draft sequence of the human genome, the Human Genome Project and follow-on projects like The Cancer Genome Atlas are underpinning advances in precision medicine.
Keeping you up to date on recent developments in orthopedics, including: Hot nano-chisel used to create artificial bones in a Petri dish; A 'skeletal age' calculator to predict bone fracture risk; Fetal surgery for spina bifida leads to better mobility in school-age children.
Australian researchers at the Walter and Eliza Hall Institute of Medical Research in Melbourne have developed new yeast- and antibody-based methods to determine how tryptophan C-mannosylation, an unusual protein glycosylation modification, impacts the stability and function of disease-relevant proteins.